BioNano Genomics's market cap is currently $12.89M. The company's EPS TTM is $-138.627; its P/E ratio is ―; BioNano Genomics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-5.90. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 36.12M	$ 27.80M	$ 17.98M	$ 8.50M	$ 10.13M
Gross Profit	$ 9.57M	$ 5.95M	$ 3.87M	$ 2.77M	$ 3.36M
Operating Income	$ -215.25M	$ -131.70M	$ -77.10M	$ -38.55M	$ -25.87M
EBITDA	$ -213.60M	$ -120.31M	$ -73.86M	$ -37.08M	$ -26.38M
Net Income	$ -232.49M	$ -132.60M	$ -72.44M	$ -41.14M	$ -29.84M
Balance Sheet
Cash & Short-Term Investments	$ 101.89M	$ 113.19M	$ 250.61M	$ 38.45M	$ 17.31M
Total Assets	$ 214.40M	$ 307.50M	$ 377.10M	$ 60.45M	$ 30.21M
Total Debt	$ 79.41M	$ 11.67M	$ 10.70M	$ 16.33M	$ 20.02M
Net Debt	$ 61.47M	$ 6.58M	$ -13.88M	$ -22.12M	$ 2.71M
Total Liabilities	$ 118.25M	$ 58.10M	$ 39.98M	$ 25.37M	$ 26.64M
Stockholders' Equity	$ 96.16M	$ 249.40M	$ 337.12M	$ 35.08M	$ 3.61M
Cash Flow
Free Cash Flow	$ -126.87M	$ -128.12M	$ -73.39M	$ -38.31M	$ -29.59M
Operating Cash Flow	$ -125.18M	$ -124.82M	$ -71.93M	$ -38.31M	$ -29.53M
Investing Cash Flow	$ 24.16M	$ 82.77M	$ -278.06M	$ -2.45M	$ -61.06K
Financing Cash Flow	$ 113.81M	$ 23.01M	$ 336.11M	$ 61.90M	$ 30.38M

Currency in USD

BioNano Genomics Earnings and Revenue History

Income Statement >

BioNano Genomics Debt to Assets

Balance Sheet >

BioNano Genomics Cash Flow

Cash Flow >

BioNano Genomics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing